Amandeep Goyal, MD

https://pubmed.ncbi.nlm.nih.gov/?term=Nora+Badiner&sort=pubdate

• Mercado KE, Badiner NM, Wang C, et al. Racial and Ethnic Disparities in Gynecologic Carcinosarcoma: A Single-Institution Experience. Cancers (Basel). 2023;15(19):4690. Published 2023 Sep 23. doi:10.3390/cancers15194690

• Brinker Feng M, Badiner N, Hong L, Ioffe Y. Searching for the source: Extraovarian primary peritoneal carcinoma presenting as chest wall masses. Gynecol Oncol Rep. 2023;47:101195. Published 2023 May 5. doi:10.1016/j.gore.2023.101195

• Badiner N, Carter C, Ioffe Y, Hong L. A case of niraparib PARP-Inhibitor induced Sweet Syndrome in gynecologic cancer. Gynecol Oncol Rep. 2023;46:101162. Published 2023 Mar 15. doi:10.1016/j.gore.2023.101162

• Frey MK, Ahsan MD, Badiner N, et al. What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing [published online ahead of print, 2022 Oct 27]. Cancer. 2022;10.1002/cncr.34482. doi:10.1002/cncr.34482

• Badiner N, Sansone S, Fenster T, Segal S. Incarcerated ventral wall hernia after robotic urogynecologic surgery: A case report. Case Reports in Women’s Health. 2021;32:e00350. Pub Status: Published.

• Li X, Kahn R, Wing N, Zhou Z, Lackner A, Krinsky H, Badiner N, Fogla R, Wolfe I, Baltich Nelson B, Thomas C, Christos P, Sharaf R, Cantillo E, Holcomb K, Chapman-Davis E, Bergeron H, Frey M. Leveraging Health Information Technology (IT) to Collect Family Cancer History: A Systematic Review and Meta-Analysis. JCO Clinical Cancer Informatics. 2021, Jan; Pub Status: Published.

• Badiner N, Nchako C, Schatz-Siemers N, Frey MK. Ovarian cancer arising from the proximal fallopian tube in a patient with a BRCA2 mutation. Gynecologic Oncology Reports. 2021, Mar; Pub Status: Published.

• Frey MK, Fowlkes R, Badiner N, Fishman D, Kanis M, Thomas C, Christos PJ, Martin P, Gamble C, Balogun O, Cardenes H, Gorelick C, Pua T, Nguyen L, Holcomb K, Chapman-Davis E. Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals. Gynecologic Oncology. 2020, Sep; 159(2): 470-475. Cited in PubMed; PMID: 32981694. Pub Status: Published.

• Badiner, N.M., Taylor, S.P., Forlenza, K., Lachman, R.S., University of Washington Center for Mendelian Genetics, Bamshad, M., Nickerson, D., Cohn, D.H., Krakow, D. Mutations in DYNC2H1, the cytoplasmic dynein 2, heavy chain 1 motor protein gene, cause short-rib polydactyly type I, Saldino-Noonan type. Clinical Genetics. 2017, Aug; 92(2): 158-162. Cited in PubMed; PMID: 27925158. Pub Status: Published.

• Beck, A.L, Takayama, J., Badiner, N.M.., Halpern-Felsher, B. Latino Parents' Beliefs about Television Viewing by Infants and Toddlers. Journal of Healthcare for the Poor and Underserved. 2015, May; 26(2): 463-474. Cited in PubMed; PMID: 25913344. Pub Status: Published.

• Beck, A.L., Takayama, J., Halpern-Felsher, B., Badiner, N., Barker, J.C. Understanding how Latino parents choose beverages to serve to infants and toddlers. Maternal and Child Health Journal. 2014, Aug; 18(6): 1308 - 1315. Cited in PubMed; PMID: 24077961. Pub Status: Published.

ABSTRACTS/PRESENTATIONS

• Badiner N, Hood K, Shah V, Ioffe Y, Hong L. Rising Burden of benign consults in gynecologic oncology. Poster. Western Association of Gynecologic Oncology Annual Meeting 2025; Colorado Springs, CO, USA.

• Badiner N, Thu An M, Kim C, Shah V, Hong L, Ioffe Y. The high stakes of substance use: worse prognosis and outcomes in cervical cancer. Poster Tour. Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2025; Seattle, WA, USA.

• Badiner N, Herberger M, Butler H, Yao R, Ioffe Y, Hong L. Take it or leave it? Incidental appendectomy at time of gynecologic oncology laparotomy. Poster. Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2025; Seattle, WA, USA.

• Badiner N, DeForest Sjahrial A, Hong L, Ioffe Y. Hormone replacement therapy improves clinical outcomes in women with iatrogenic menopause secondary to cervical cancer treatment. Virtual Poster. Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2025; Seattle, WA, USA.

• Donkor K, Jang H, Badiner N, Ioffe Y, Hong L. Conventional Prophylactic Regimen of Oral Dexamethasone Versus Short-course Intravenous Dexamethasone to Prevent Paclitaxel-related Hypersensitivity Reactions in Gynecologic Oncology Patients. Virtual Poster. Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2025; Seattle, WA, USA.

• Ritchie J, Badiner N, Conant A, Hong L, Ioffe Y, Unternaehrer J. In vivo chemotherapy exposure alters expression of stemness and epithelial mesenchymal transition factors in high grade serous ovarian cancer samples. Poster Tour. Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2025; Seattle, WA, USA.

• Ritchie J, Badiner N, Conant A, Suzuki T, Hong L, Ioffe J, Unternaehrer J. (June 2024). In Vitro Low Passage Patient Derived Cells Demonstrate Lack of Faithfulness to Original Sample. Poster presented at: Western Association of Gynecologic Oncologists Annual Meeting; Seattle, WA, USA.

• Ritchie J, Badiner N, Conant A, Suzuki T, Hong L, Ioffe J, Unternaehrer J. (June 2024). In Vitro Characterization of Patient Derived Samples Demonstrates the Heterogeneity of High Grade Serous Ovarian Cancer. Poster presented at: Western Association of Gynecologic Oncologists Annual Meeting; Seattle, WA, USA.

• Badiner N, Ashrafian S, Ioffe Y, Hong L. (March 2024). Hormone Replacement Therapy in Ovarian Cancer Survivors: Clinical Considerations to Optimize Patient Care. Poster presented at: Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2024; San Diego, CA, USA.

• Conant A, Chirshev E, Suzuki T, Badiner N, Damoah RL, Pira C, Oberg K, Unternaehrer J. (November 2023). Identification of Transcriptional Regulatory Mechanisms of let-7 in Early Murine Development. Poster presented at: Inland Empire Stem Cell Consortium; San Bernardino, CA, USA.

• Conant A, Chirshev E, Suzuki T, Badiner N, Damoah RL, Pira C, Oberg K, Unternaehrer J. (October 2023). Investigation of the Relationship of Transcription Factor Snail and microRNA let-7 in Early Murine Development. Poster presente at: Loma Linda University 26th Annual Basic Sciences Research Symposium.; Loma Linda, CA, USA.

• Badiner N, Conant A, Suzuki T, Antonissen A, Hong L, Ioffe Y, Unternaehrer J. (June 2023). Overexpression of the microRNA let-7i does not consistently enhance sensitivity to chemotherapy in vitro in patient-derived epithelial ovarian carcinoma cell samples. Poster presented at: Western Association of Gynecologic Oncologists Annual Meeting; Monterey, CA, USA.

• Badiner N, Conant A, Fernandez J, Hong L, Ioffe Y, Unternaehrer J. (June 2023). In vitro chemosensitivity of patient-derived epithelial ovarian cancer samples to cisplatin and olaparib are not correlated with homologous recombination deficiency, clinical platinum sensitivity, or cancer stem cell frequency. Poster presented at: Western Association of Gynecologic Oncologists Annual Meeting; Monterey, CA, USA.

• Guthrie L, Badiner N, Ghui R, Graybill C, Kasumba M, Hayton R, Lum S, Hong L, Reeves M, Ioffe Y. (June 2023). HIV prevalence and abnormal screening rates at a single institution providing cervical cancer screening and treatment in Malawi. Oral Presentation at: Western Association of Gynecologic Oncologists Annual Meeting; Monterey, CA, USA.

• Badiner N, Conant A, Suzuki T, Hong L, Ioffe Y, Unternaehrer J. (May 2023). Replacing let-7i: A Novel Method of Overcoming Ovarian Cancer Chemoresistance? Oral Presentation: Loma Linda University Department of Obstetrics & Gynecology Annual Research Symposium: Loma Linda, CA, USA.

• Conant A, Suzuki T, Chirshev E, Badiner N, Unternaehrer JJ. (August 2022). Characterization of Cancer Stem Cell Chemoresistance in HGSOC. Poster presented at: Loma Linda University CHDMM Summer Symposium; Loma Linda, CA, USA

• Badiner N, Fenster T. (November, 2021). Incidence, Diagnosis and Treatment of Broad Ligament Fibroids in Women undergoing Minimally Invasive (MIS) Myomectomy: A Chart Review. Poster presented at: 50th AAGL Global Congress on Minimally Invasive Gynecology; Austin, TX, USA.

• Badiner N, Ahsan M, Fowlkes R, Nitecki R, Rauh-Hain JH, Cornelius-Schecter A, Kahn R, Chapman-Davis E, Tubito F, Christos PJ, Sharaf R, Holcomb, K, Frey MK. (March, 2021). Long-term follow-up of facilitated cascade genetic testing for familial cancer syndromes: Do at-risk relatives act on the information gained and what are the quality-of-life implications? Poster presented at: Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2021; Virtual.

• Kahn R, Badiner N, Nicholson N, Cantillo E, Gordhandas S, Smith C, Siddiqui M, Holcomb K, Frey M, Chapman-Davis E. (March, 2021). Without mandatory high-risk HPV co-testing, are we inadequately screening for adenocarcinoma of the cervix? Poster presented at: Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2021; Virtual.

• Li X, Kahn R, Zhou ZN, Lackner AI, Krinsky H, Badiner N, Fogla R, Wolfe I, Baltich Nelson B, Thomas C, Christos PJ, Sharaf RN, Cantillo E, Holcomb K, Chapman-Davis E, Frey MK. (March, 2021). Leveraging health information technology to collect family cancer history: A systematic review and meta-analysis. Poster presented at: Society of Gynecologic Oncology Annual Meeting on Women’s Cancer 2021.

• Badiner, N.M. (July, 2015). Mutations in the IFT-A motor protein, Dynein, cytoplasmic 2, heavy chain 1 (DYNC2H1) cause Short-Rib Polydactyly Syndrome type 1, or Saldino-Noonan Syndrome Poster presented at: Josiah Brown Poster Fair at DGSOM; Los Angeles, CA, USA.